RAD-AR News Vol.12, No.1 (May 2001) 2
|
|
|
- ともみ のえ
- 7 years ago
- Views:
Transcription
1 RISK / BENEFIT ASSESSMENT OF DRUGS-ANALYSIS & RESPONSE RAD-AR Series No
2 RAD-AR News Vol.12, No.1 (May 2001) 2
3 3
4 RAD-AR News Vol.12, No.1 (May 2001) 4
5 5
6 RAD-AR News Vol.12, No.1 (May 2001) 6
7 7
8 RAD-AR News Vol.12, No.1 (May 2001) 8
9 9
10 RAD-AR News Vol.12, No.1 (May 2001) 10
11 11
12 Ito&Associates, Inc. RAD-AR News Vol.12, No.1 (May 2001) 12
13 13 Cancer Survivors Network Stevens Jonson Syndrome Foundation
14 RAD-AR News Vol.12, No.1 (May 2001) 14
15 15
16 RAD-AR News Vol.12, No.1 (May 2001) 16
17 17
18 RAD-AR News Vol.12, No.1 (May 2001) 18
19 19
20 RAD-AR News Vol.12, No.1 (May 2001) RISK / BENEFIT ASSESSMENT OF DRUGS-ANALYSIS & RESPONSE t s RADARRiskBenefit Assessment of Drugs-Analysis and Response RADARRADAR Council, Japan=RCJRADAR Pharmacoepidemiology RADAR RADAR News Volume 12, No.1Series No RADAR F Tel Fax http//wwwrad-arorjp/
RAD-AR News Vol.12, No.6 (Mar. 2002) 2
RISK / BENEFIT ASSESSMENT OF DRUGS-ANALYSIS & RESPONSE RAD-AR Series No.49 2 5 6 8 9 10 12 14 15 16 RAD-AR News Vol.12, No.6 (Mar. 2002) 2 3 RAD-AR News Vol.12, No.6 (Mar. 2002) 4 5 RAD-AR News Vol.12,
RAD-AR News Vol.11 (Oct. 2000) 2
RISK / BENEFIT ASSESSMENT OF DRUGS-ANALYSIS & RESPONSE RAD-AR ts 1 2 1 1 3 1 1 RAD-AR News Vol.11 (Oct. 2000) 2 3 RAD-AR News Vol.11 (Oct. 2000) 4 5 RAD-AR News Vol.11 (Oct. 2000) 6 ts 7 RAD-AR News Vol.11
RAD-AR News Vol.11, No.5 (Jan. 2001) 2
RISK / BENEFIT ASSESSMENT OF DRUGS-ANALYSIS & RESPONSE RAD-AR Series No.42 2 3 6 7 10 13 15 16 9 8 12 RAD-AR News Vol.11, No.5 (Jan. 2001) 2 2000 10 22 3 RAD-AR News Vol.11, No.5 (Jan. 2001) 4 5 RAD-AR
2 RAD-AR News Vol.14, No.5 (Jan. 2004)
Series No. 60Jan. 2004 CONTENTS 2 RAD-AR News Vol.14, No.5 (Jan. 2004) 3 4 RAD-AR News Vol.14, No.5 (Jan. 2004) 5 RAD-AR News Vol.14, No.5 (Jan. 2004) 6 7 RAD-AR News Vol.14, No.5 (Jan. 2004) 8 9 1100
RAD-AR News Vol.14, No.6 (Mar. 2004) 2
Series No. 61Mar. 2004 CONTENTS RAD-AR News Vol.14, No.6 (Mar. 2004) 2 3 RAD-AR News Vol.14, No.6 (Mar. 2004) 4 5 6 RAD-AR News Vol.14, No.6 (Mar. 2004) 7 8 RAD-AR News Vol.14, No.6 (Mar. 2004) 9 RAD-AR
vol61_H1_H4_入校 のコピー.ai
A N G E volume 61 A N G E 1 2 3 4 59 3 news n e w s news volume.54 5 6 7 8 103 211 1225 112 13122 22343 110 214 21538 118 131 21 211 32122 329 137 31 110 124 228 328 1 118 211 116 216 216 222 308 2 124
NEWS LETTER vol.40 01
NEWS LETTER vol.40 01 NEWS LETTER vol.40 02 03 NEWS LETTER vol.40 NEWS LETTER vol.40 04 05 NEWS LETTER vol.40 NEWS LETTER vol.40 06 NEWS LETTER vol.40 07 NEWS LETTER vol.40 08 09 NEWS LETTER vol.40 NEWS
RAD-AR News Vol.15, No.4 (Nov. 2004) 2
Series No. 65Nov. 2004 CONTENTS RAD-AR News Vol.15, No.4 (Nov. 2004) 2 3 4 RAD-AR News Vol.15, No.4 (Nov. 2004) 5 RAD-AR News Vol.15, No.4 (Nov. 2004) FDAの リスクマネジメントプランのための ドラフトガイダンス案 について くすりの適正使用協議会
2 1
http://www.kikkoman.co.jp/ 2 1 21,646 11,219 5,275 17,350 6,056 20,983 2,777 10,793 4,327 10,125 10,739 128,391 359,906 119,975 392,611 59,993 202,727 18,557 1,401 4,052 4,045 5,702 5,852 2,378 103,445
15.06月号.indd
2015. no521 6 2015.6 News 2015.6 News News 2015.6 2015.6 News News 2015.6 News 2015.6 2015.6 2015.6 2015.6 2015.6 2015.6 2015.6 2015.6 2015.6 2015.6 2015.6 2015.6 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16
15.03月号.indd
2015. no518 3 2015.3 2015.3 News 2015.3 2015.3 News News 2015.3 2015.3 2015.3 2015.3 2015.3 2015.3 2015.3 2015.3 2015.3 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30
14.08月号.indd
2014. no511 8 News 2014.8 News 2014.8 News 2014.8 News 2014.8 2014.8 2014.8 News 2014.8 2014.8 2014.8 2014.8 2014.8 2014.8 2014.8 2014.8 2014.8 2014.8 2014.8 2014.8 2014.8 2014.8 2014.8 1 2 3 4 5 6 7 8
mr0805.indd
62 MAY 2008 MAY 2008 63 64 MAY 2008 MAY 2008 65 66 MAY 2008 MAY 2008 67 68 MAY 2008 MAY 2008 69 70 MAY 2008 MAY 2008 71 72 MAY 2008 MAY 2008 73 74 MAY 2008 MAY 2008 75 76 MAY 2008 MAY 2008 77 78 MAY 2008
CHORD5....-1
5 Vol.62/2009 CHORD VOL.62 2009 MAY CHORD VOL.62 2009 MAY CHORD VOL.62 2009 MAY CHORD VOL.62 2009 MAY CHORD VOL.62 2009 MAY CHORD VOL.62 2009 MAY CHORD VOL.62 2009 MAY CHORD VOL.62 2009 MAY CHORD VOL.62
™…
2/10 15 2010. No1362 1 1 216315 91430 Q A & 0.23% 1 1.4% 04-7120-2020 050-5540-2023 Q A & 1 1 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 1 1 2 3 4 5 6 7 8 9 10
EPSON
B K L & & & & & & & & L & & & & & & & K & & & & & L L L & & & K L L L & & L L L & & & & & & & & & & & & & & & & & & & & & & & & & & & L & K L K & & & & & & & L L & & L & & L L & & & & &
2.8% 2.0% 2.4% 2.4% 0.4% 0.1% 0.3% 0.5% 3.8% 5.6% 25.6% 29.3% 64.6% 60.0% 1
2.8% 2.0% 2.4% 2.4% 0.4% 0.1% 0.3% 0.5% 3.8% 5.6% 25.6% 29.3% 64.6% 60.0% 1 16 24 21 20 20 23 10 11 9 10 3 3 3 2 3 1 3 4 6 8 2 0 1 2 3 4 5 6 0 1 2 3 4 5 6 0 1 2 3 4 5 6 3 4 Q & A Q1 A1 Q2 A2 Q3 A3 7
Q&A最低資本金特例030131.PDF
& 1 2 2 3 2 2 3 2 2 3 10 11 10 90 12 13 14 15 16 17 18 19 20 2 2 3 21 2 2 3 22 23 24 25 20 10 26 27 28 10 8 1 29 30 10 8 2 31 32 2 2 3 33 10 8 3 10 11 2 34 10 8 3 10 12 2 35 36 20 10 37 38 39 40 41 42
bumon_pro.indd
q w e r t y u i o!0 !1!2!3 !4!5!6 !7!8!9 @0 @1 @2 @3 @4 @5 @6 @7 @8 @9 #0 #1 #2 #3 #4 #5 #6 #7 #8 #0 $0 $1 $2 $3 $4 $5 $6 $7 $8 $9 %0 %1 %2 %3 %4 %5 %6 %7 %8 %9 ^0 ^1 ^2 ^3 ^4 ^5 ^6 ^7 ^8 ^9 &0 &1 &2
2012_10_A_cover.indd
c %& r Z \ W n % & & % % & % & & % % % & % & % & & % & % %& % & % & % % % & & & W W W W A
‡o‡P†C‡P‡Q”R„û†^‡P†C‡P‡Q
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,, Q & A ,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
2012_05_GLK_cover.indd
c %& r Z \ W W n q & F % % & & % & & % % % & % & % & % & % & % & F F % % % & & & & % & A
みさき_1
2 3 4 5 6 7 1F 2F 8 9 10 11 17 18 19 20 21 22 23 24 31 25 26 27 28 29 30 8 1 2 3 4 5 6 7 6 8 7 16 7 8 9 10 11 12 14 15 13 17 23 Vol.41 8 6 20 11 7 15 7 23 7 7 7 16 23 23 8 13 18:00 22:00 722
Vol..3 2010 2 10 2
1 Vol..3 2010 2 10 2 Vol..3 2010 2 10 3 Vol..3 2010 2 10 4 Vol..3 2010 2 10 5 Vol..3 2010 2 10 6 Vol..3 2010 2 10 7 Vol..3 2010 2 10 8 Vol..3 2010 2 10 9 Vol..3 2010 2 10 10 Vol..3 2010 2 10 11 Vol..3
H21_report
vol.4 1 2 6 10 14 18 20 22 24 25 1 2 2172 73 3 21925 926 21125 126 4 5 6 21629 630 7 21107 108 21127 128 8 9 10 21616 617 11 211026 1027 211213 1214 12 13 14 21713 714 15 2194 95 211031 111 16 17 18 19
2009-9-2.indd
Q No.1441 Q No.1442 Vol.33 NO.9 (2009) 30 (614) Q No.1443 Vol.33 NO.9 (2009) 31 (615) Q No.1444 Vol.33 NO.9 (2009) 32 (616) Vol.33 NO.9 (2009) 33 (617) Vol.33 NO.9 (2009) 34 (618) Q No.1445 Vol.33 NO.9